Damien Gloria MD Catonsville, MD - 21228

Damien Gloria MD is categorized under Primary Care Centers in Catonsville, MD and active since 1991.

Damien Gloria MD was established in 1991, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Gloria Damien at the company’s single location by writing to 724 Maiden Choice Lane # 304, Catonsville, Maryland MD 21228 or by phoning (410) 719-0800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Damien Gloria MD
Contact Person: Gloria Damien
Address: 724 Maiden Choice Lane # 304, Catonsville, Maryland 21228
Phone Number: (410) 719-0800
Website Address: physicians.catonsville.ypeek.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1991
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Primary Care Centers
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Damien Gloria MD was started in 1991 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Gloria Damien for inquiries that concern Damien Gloria MD by calling the company number (410) 719-0800, as your correspondence is most welcome. Additionally, the physical location of the single location of Damien Gloria MD can be found at the coordinates 39.26864,-76.70564 as well as the street address 724 Maiden Choice Lane # 304 in Catonsville, Maryland 21228.

For its online presence, you may visit Damien Gloria MD’s website at physicians.catonsville.ypeek.com and engage with its social media outlets through on Twitter and on Facebook.